author-photo

Ivan Nestorov

Biogen Idec

47

Papers

975

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Population pharmacokinetics–based recommendations for a single delayed or missed dose of nusinersen

2021 Neuromuscular Disorders
Show All
- Source
- Cite
- Save
Citations (0)
Prediction of in vivo performance of oral extended release (ER) formulations prior to clinical evolution: A case study for enteric coated polymeric beads formulation.

2021 European Journal of Pharmaceutics and Biopharmaceutics
Show All
- Source
- Cite
- Save
Citations (0)
EMERGE et ENGAGE : premiers résultats des études de phase III sur l’aducanumab dans la maladie d’Alzheimer au stade précoce

2021 Revue Neurologique
Show All
- Source
- Cite
- Save
Citations (0)
A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.

2021 Journal of Pharmacokinetics and Pharmacodynamics
Show All
- Source
- Cite
- Save
Citations (1)
Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease: Developments in clinical trials and cognitive assessment

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (20)
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (95)
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus.

2020 Journal of Pharmacokinetics and Pharmacodynamics
Show All
- Source
- Cite
- Save
Citations (4)
In-vivo Intrathecal Tracer Dispersion in Cynomolgus Monkey Validates Wide Biodistribution Along Neuraxis

2019 IEEE Transactions on Biomedical Engineering
Show All
- Source
- Cite
- Save
Citations (7)
A Semi‐Mechanistic Population Pharmacokinetic Model of Nusinersen: An Antisense Oligonucleotide for the Treatment of Spinal Muscular Atrophy

2018
Show All
- Source
- Cite
- Save
Citations (7)